Treating PPMS
Should all people with so called primary progressive MS (PPMS) be offered a disease-modifying therapy?
Now that we have a licensed treatment for PPMS do you think it is still ethical to do placebo controlled trials?
Do you agree with reclassifying MS as one disease and getting rid of the terms primary and secondary progressive MS?
Do you understand what is meant by the term active MS?
Do you understand what is meant by the term worsening MS independent of relapses?
Your answer
No personal identifiers will be collected as part of this audit. By completing this survey you are consenting to the data you provide being analysed by Professor Giovannoni and the MS Team at Barts Health NHS Trust. Results of this survey will be analysed, written-up, presented to the Barts-MS team and may be submitted for publication.
Never submit passwords through Google Forms.
This form was created inside of Gavin Giovannoni.